SlideShare a Scribd company logo
Brachytherapy Dosimetry
(TG 43 Formulation)
SABARI KUMAR P
M.Sc. Radiation Physics
OUTLINE
Introduction
Sources used in Brachy
Source Specification and its relation
Source Calibration Methods
Exposure Rate Method
Well type chamber Method
Solid Phantom Method
 Dose Distribution around sources
TG 43 Formulation
Introduction
Brachytherapy also named as Curie Therapy or Radium Therapy
It is a special type of Radiotherapy treatment technique in which
irradiation happen by placing radio nuclide inside or near the tumor
A high dose can be delivered locally to the tumor with rapid dose
falloff in the surrounding tissues
It generates highly conformal dose distribution in the target volume
Mainly two types of sources are used such as:
Sealed sources: Two sources with same activity may emit different
amount of energy due to encapsulation. Hence dose rate may differ.
 Unsealed sources: Due to no encapsulation, two sources with same
activity emit same amount of energy. Hence dose rate becomes same.
Based on source placement,
different classifications done in
Brachytherapy such as
 Intracavitary Brachytherapy :
- source is placed in body cavities
 Interstitial Brachytherapy
- source is inserted into tumor
 Surface Mould
- source is placed externally near the tumor
 Intra Luminal & Intra Vascular
- sub classification of Intracavitary
Based on dose rate used to treat tumor again Brachytherapy classified
as
Low dose rate (LDR) : <2Gy/h dose rate
Medium Dose rate (MDR): >2Gy/h to <10Gy/h dose rate
High Dose rate(HDR) : >10Gy/h dose rate
Pulse Dose rate (PDR) : <1Gy/h HDR becomes used as PDR
Based on source used in Brachytherapy, again two techniques
introduced such as
Permanent Implantation : Au-198, I-125, Pd-103
Temporary Implantation : Cs-137, Ir-192, Co-60 and Ra-226
Desirable Properties of Brachytherapy Sources:
 Source may be naturally available or artificially obtained
 Optimum Gamma ray emission should be high enough to avoid
increased energy deposition in bone and to minimize scatter. At the
same time, it must be low to meet protection requirements
 Long Half life is required for permanent storage and decay correction
should minimum
 Charged Particle emission should be absent
 Should not be gaseous disintegration product
 should have high specific activity
 Possible to available in different shapes, sizes
 should be insoluble, nontoxic and not in powder form
Sources used in Brachytherapy
1. Radium -226: First source used in Brachytherapy. It is a naturally
available source. It decays to Pb-206 by emitting 0.83MeV (Average)
energy. Due to high exposure, hazardous bi-product (Radon – 222)
and low specific activity ( 0.98 Ci/g) present usage stopped
permanently.
2. Cesium 137: Cs- 137 is a nuclear fission by product and decays to
Ba -137 by emitting 0.662MeV gamma energy. Its low specific
activity (50Ci/g) limited this usage in LDR only.
3. Cobalt – 60: Co-60 is a neutron activated product, which decays to
Ni-60 by emitting 1.25MeV (Average) energy. High specific activity
(200 Ci/g) makes its wide usage in Brachy earlier. But due to short
half life (5.26Y) and cost effective, no longer used at present in
Brachy.
4. Gold – 198: Au-198 is produced by nuclear activation and it decays
to Hg-138 by emitting 0.412MeV energy. Short half life ( 2.6days)
makes this usage in permanent implantation technique.
5. Iodine – 125: It decays via Electron Capture to Te-125 and emits
0.35MeV gamma energy. Relatively longer half life (59.4 days),
gained more advantage in permanent implant technique over
Au-198, Rn-222. But dosimetry is much more complex due to
complex energy spectrum.
6. Palladium – 103: It is the substitute for I-125. It decays to Rh-103 via
electron capture and emits 0.021MeV energy. Having short half life
(17 days) compared to I-125, it may provide biologic advantage in
permanent implants.
7. Iridium -192: It is more popular as a replacement of Ra-226. It
decays to Pt-192 by emitting 0.361MeV (Average) energy. High
Specific activity ( 400 Ci/g) and short half life (73.8 days) makes this
source more popular in temporary implantation in HDR.
8. with all above, few of other Radioactive isotopes such as
Ytterbium – 169, Thulium – 170, Phosphor – 32, Yttrium - 90 and
Californium – 252 also used in Brachytherapy.
Source Specification
Each Brachy source has a specified source strength that is used to
calculate dose rate.
Source strength can be stated in terms of one of several interrelated
physical quantities such as – Radium Equivalent Mass, Apparent Activity,
Air Kerma Rate (RAKR), Air kerma Strength, Exposure Rate .
Radium Equivalent Mass:
Ra-226 was predominant source in Brachy in early days. So source
strength was defined by Mass of Ra
For non Radium sources, strength can be specified by Ra Eq. Mass
Relation between mg Ra Eq and its activity is
1 mg Ra Eq = 1 mCi of Ra
Exposure Rate Constant:
The exposure rate constant defines as the Exposure at a unit distance
from the point source of activity A
gamma
Here Ʈδ = Exposure Rate constant (R–m2/Ci – hr (or) R-cm2/mCi - hr)
r = Distance from source and Measurement point (P) (m2)
X(P) = Exposure at point P (R)
A = Activity of source (Ci)
Conditions :
1. Source should be a bare point source
2. The photon fluence is neither attenuated nor scattered in the
distance ‘r’
3. When δ = 0, the exposure rate constant includes all the photons
emitted by the radionuclide
A
)P(X.r2

Air Kerma Rate Constant:
From the relation between exposure (X), air kerma (Ka) and Exposure
rate constant,
Here Ka is expressed in μGy/hr
Units: μGy – m2/Ci – hr
Reference Air Kerma Rate (RAKR):
If Air kerma rate is defined at 1 meter distance and corrected for air
attenuation and scattering, then it becomes Reference Air Kerma Rate
(RAKR).
It is indicated by KR(dref)
Units: Gy/Sec
a
2
k, K
A
r

Apparent Activity:
Basically, the source is not bare point source. It is encapsulated by
filter material which introduces an attenuation. Thus reduction in air
kerma rate happens. To compensate this attenuation effect, Apparent
Activity is introduced.
If the source is calibrated under Air kerma rate conditions, the source
strength may be specified as Apparent Activity or Effective Activity.
Here Aeff = A x Katt
Katt – source encapsulation attenuation
Thus, Apparent activity can be determined by dividing measured air
kerma with Air kerma rate constant (or) exposure rate with exposure
rate constant.
Ka
a
2
eff
)P(K.r
A


Air Kerma Strength:
This was introduced by AAPM in 1987 to replace exposure rate.
The product of air kerma rate in free space and the square of the
distance of calibration point from the source centre is called as Air
kerma Strength.
Sak = Ka x r2 (or) Ʈak x Kattn x A
Units: μGy m2/hr
 For linear sources, Ka is measured at a point along the mid
perpendicular line of the source at a distance very much larger than
active length of the source.
1 μGy – m2/hr = 0.138 mg Ra Eq
 AAPM 43 recommends a shorthand
notation for air kerma strength as “U”
1 U = 1 μGy – m2/hr
Standardization of Brachytherapy Sources
As like external beam therapy measurements, Brachytherapy
measurements should also be traceable to the Primary standardization
lab.
In Brachy, sources are standardized in terms of RAKR or Air kerma
Strength.
Based on the source strength, three methods are developed.
1. Measurement using air setup with ion chamber
2. Measurement using well type ion chamber
3. Measurement using Solid Phantom of well defied geometry
In Air measurement setup
Measurement using Air setup:
The arrangement consists of a large source to ion chamber distance
relative to source and detector dimensions.
 For this a calibrated large volume chamber can be used for low
activity sources.
Calibration method for large volume chamber in Lab :
Ka at 1 meter (at point P) for working standard : X Gy/h
current at P for the large volume chamber : Y pA
Air kerma calibration factor NK = (X/Y) Gy/pA . hr
For a source to be calibrated , consider the current reading Y’ at point
P, then
Ka of the source at P = NK . Y’ Gy/h
After applying Air attenuation factor (Kattn) and Scatter Radiation
correction factor (Kscatt) and non uniformity correction factor (Kn)
the KR becomes
KR = NK. Kattn . Kscatt . Kn . Y’
Corrected Reading Y’ = M . Ku. Kt. KP. KTP. Kion. Kv. Kwall. Kappl
M – Meter Reading (pA)
Ku – Unit conversion factor from air to water/medium
Kt – Transit time correction factor
KP – Polarity correction factor
KTP – Temperature and Pressure correction factor
Kion – Ion recombination factor
Kv – chamber volume correction factor
Kwall – chamber wall attenuation & scattering correction factor
Kappl – Applicator attenuation correction factor
Generally NK – air kerma calibration factor for Co-60 and Cs-137 can
provided by PSDL or SSDL. For other than these sources, Interpolation
between two neighboring calibration point is used.
 For low energy radio nuclides ( I-125 and Pd-103) large volume
chambers are required at the same time, for routine clinical procedures,
this method is not practical.
Well chamber Measurement:
Most widely used method for calibration sources of any radio nuclide
by using Well type ion chamber (or) 4πr-chamber (or) isotope calibrator
(or) Re-entrant type ion chamber.
Calibration of well chamber is made either
1. with source previously calibrated using air setup
2. with source of the same radio nuclide calibrated by a PSDL
These chambers are calibrated in terms
of RAKR or Air kerma Strength.
Source Strength of a Brachy source by using
well chamber is determined from,
KR = NKR . M . KP . KTP . Kion. Kappl
Here,
NKR – RAKR calibration factor of chamber
Cont..
Due to thicker walls of well type chamber, the energy and source type
dependence of the response of well type chambers are much more
pronounced.
Energy dependence of the chamber arises from absorption and
scattering of photons and secondary electrons in the chamber walls and
the gas.
The oblique filtration through the source encapsulation affects the
chamber response by photon absorption and thus produces change in
the energy spectrum.
Source dimensions and source position in well chamber also affects
the chamber response.
Measurement using Solid Phantom:
Phantom Measurement is superior than air measurement and
equivalent to well type chamber measurement.
 The RAKR or Air Kerma Strength depends on phantom specific
geometry, material and radio nuclide to be used.
 The generalized formula for all sources and
all solid phantom designs published by DGMP as
KR = NK . M . KαP . Kph
Here
NK – Chamber Calibration Factor
M – corrected Meter Reading
KαP - Perturbation correction factor
(Medium changing from air to Phantom)
Kph - Phantom correction factor density correction factor
from water to water equivalent meterial
 To minimize the source position dependence,
a plastic SF catheter is used.
Dose Distribution of Brachy sources
In early days the treatment were purely empirical based on trail and
error i.e certain amount of Ra (mg) is placed for certain (hours) to treat
various types of tumors. This was popular as “mgh” method. But at
present, new techniques came for dose distribution calculations around
the source.
The kerma rate at a point in air or in tissue from seed can be
calculated using Air kerma Rate Constant
The dose at a point from line source can be determined using Sievert
Integral Method.
For ideal Point source:
1. The air kerma rate can be calculated based on the RAKR and inverse
square law, at point of interest in air becomes
Ka(r) = Kr (r0/r)2
2. The absorbed dose rate to air in air becomes
Da(r) = Kcol,a(r)
= Ka(r) . (1.- g) = Kr . (1- g) . (r0/r)2
3. The absorbed dose rate to water in air medium becomes
Dw(r) = Da(r) . (μen/ρ)a,w
= Kr . (1- g) . (r0/r)2 . (μen/ρ)a,w
4. The absorbed dose rate to water in water medium becomes
Dw(r) = Kr . (1- g). (r0/r)2 . (μen/ρ)a,w . fas,w(r)
In terms of Air kerma strength,
Dw(r) = Sk. (1- g). (1/r)2 . (μen/ρ)a,w . fas,w(r)
From the above equation, one can conclude that the absorbed dose is
depends on emitted photon energy spectrum (radio nuclide ) , distance,
absorption and scattering on medium , g value and mass energy
absorption coefficient.
But Practically g values are zero for Brachytherapy sources. The mass
energy absorption coefficient for high energy radio nuclides is
insensitive to source designs. Thus the photon spectra changes due to
source design only. So the above equation can re-written as
Dw(r) = Kr . (r0/r)2 . (μen/ρ)a,w . fas,w(r)
For Line source: (In air)
In real situation, the source is not a point source. Sources have finite
dimensions. At This condition, the total source length is dividing into
small elementary sources and applying Inverse Square Law and
filtration corrections to each
Consider a source of active Length ‘L’ and filtration ‘t’.
The kerma rate Ka at point ‘P’ contributed by
the source element dx length is given by,
Here
A – Activity
Ʈka – Air Kerma rate constant
μ’ – Effective attenuation co-efficient for filter
By integrating the above equation and taking account of θ1 and θ2


 



de
L
dx
Y
A
)P(K
2
1
/
tSec.ka
a

 tSec.
2
ka
a
/
e
L
dx
r
A
)P(dK
This equation is called Sievert Integral equation and can be evaluated
by numerical method.
To compute accurately air kerma rate using this method such as
1. Self Absorption correction in the source material is needed
2. Wall thickness should be corrected to internal radius of source i.e.
Effective attenuation co efficient needed with filter thickness
Inverse square Law effect:
 In the linear sources, at points
close to source, the exposure rate
is less. (due oblique filtration)
 As distance increases, the response
of line source follows as like as point
source response.
In Medium:
 For calculation of the dose in water or medium, the perturbation
correction (WPC) for this distance, WPC(Y Secθ) should be
incorporated in the integral expression.
Here
WPC – (Kattn)w.(Kscat)w
Limitations:
The Sievert Integral method will not account for filtration in the paraxial
regions (A & A’) (introduces significant errors and practically break
downs in the extreme oblique directions)
A A’
)YSec(WPC.de
L
dx
Y
A
)P(K
2
1
/
tSec.ka
a 

 



Modular Dose Calculation Model : TG 43
In 1995, AAPM – TG 43 taken calculation model proposed by ICWG
and published recommendations on dosimetry formalism and dosimetry
parameters for Interstitial Brachytherapy sources.
Primarily, these were considered only for LDR sources. But later,
virtually implemented to HDR and PDR also.
Previous dose calculations were based on apparent activity,
Eq. Mass of Ra, Exposure Rate constants and tissue attenuation
coefficients. These did not account for source to source differences in
active core constructions and encapsulation design.
The TG 43 introduced and incorporated dose rate constants and
specific source design dosimetric parameters.
TG 43 is simple to implement and small number of parameters are
used which can easily extract form Monte Carlo calculated dose rate
distribution around the sources in a water equivalent medium.
For the reference point of TG 43 formalism becomes,
Dw(r0,θ0) = Kr . G(r0,θ0) . (μen/ρ)a,w . fas,w(r0,θ0) -----------(1)
For the point of interest, TG 43 formalism becomes,
Dw(r,θ) = Kr . G(r,θ) . (μen/ρ)a,w . fas,w(r,θ) -----------(2)
From the above equations,
Dw(r,θ) = Dw(r0,θ0). G(r,θ)/ G(r0,θ0) . fas,w(r,θ)/ fas,w(r0,θ0)
= Sk . Dw(r0,θ0)/Sk . G(r,θ)/ G(r0,θ0) . fas,w(r,θ)/ fas,w(r0,θ0)
Finally , the equation can re written as,
Dw(r,θ) = Sk . Λ . G(r,θ)/ G(r0,θ0) . g(r) . F(r,θ)
Where,
Λ = Dw(r0,θ0)/Sk (dose rate constant)
g(r) . F(r,θ) = fas,w(r,θ)/ fas,w(r0,θ0)
P
R
θ
θ
Reference Medium :Water (Homogeneous medium)
Reference Data : Monte Carlo Simulation data
Source Geometry : All Clinically approved source dimensions
Reference Dose calculation
point : A point lying on the transverse
bisector of the source at a distance
of 1cm from its center that’s why r0
Point of Measurement : Dose rate at point which is on radial line
at an angle w.r.to source
Formalism: Dose = S x dose rate constant x inverse square law factor x
absorption/scatter correction factor in the medium x
absorption/scattering correction factor in the source
Here Sak – Air kerma strength in U
G(r,θ) – geometric function at radial distance r and polar angle θ
for point source ==> G(r,θ) = 1/r2
for line source ==>G(r,θ) = (θ -θ )/LY
),r(F)r(g
),r(G
),r(G
S),r(D
00
ak 



G(r0,θ0) – geometric function at reference point (r0 = 1 cm and θ0 =900)
g(r) – Radial dose function which depends on photon absorption and
scatter in the medium along the transverse axis
F(r,θ) – anisotropy function that considers the effects of absorption and
scatter of the photons within the source active core and
encapsulation material.
It is defined as The angular dependence of the dose rate value
for a given radial distance r, corrected for the distance related effect
using the effective inverse square law correction.
)90,cm1r(G)90,cm1r(D
)90,cm1r(G)90,r(D
)r(g 0
00
0
00
0
00
0



),r(G)90,cm1r(D
)90,cm1r(G),r(D
),r(F 0
00
0
00



Λ (Lamda) – Dose rate constant
It is defined as the dose rate to water in water at the reference
point (1cm, 00) per unit air kerma strength Sk.
This will depends on both the radionuclide and source design.
If source is a point source then,
Φan – distance dependent average anisotropy function
φan = 4π average dose rate /dose rate along the transverse axis
ak
0
00
S
)90,cm1r(D 

an2ak )r(g
r
1
S)r(D 
THANKYOU…
Need to better well

More Related Content

What's hot

EXTERNAL PHOTON BEAMS THERAPY (PART 2)
EXTERNAL PHOTON BEAMS THERAPY (PART 2)EXTERNAL PHOTON BEAMS THERAPY (PART 2)
EXTERNAL PHOTON BEAMS THERAPY (PART 2)
Nik Noor Ashikin Nik Ab Razak
 
Principles of beam direction and use of simulators
Principles of beam direction and use of simulators Principles of beam direction and use of simulators
Principles of beam direction and use of simulators
Anil Gupta
 
Isodose lines
Isodose linesIsodose lines
Isodose lines
Tata Memorial Centre
 
Dose volume histogram
Dose volume histogramDose volume histogram
Dose volume histogram
Sasikumar Sambasivam
 
Measurement of absorbed dose
Measurement of absorbed doseMeasurement of absorbed dose
Measurement of absorbed dose
Purvi Rathod
 
Mlc
MlcMlc
Manchester system_Dr.Supriya
Manchester system_Dr.SupriyaManchester system_Dr.Supriya
Manchester system_Dr.Supriya
Supriya Sonaje
 
Dosimetric Evaluation of High Energy Electron Beams Applied in Radiotherapy
Dosimetric Evaluation of High Energy Electron Beams Applied in RadiotherapyDosimetric Evaluation of High Energy Electron Beams Applied in Radiotherapy
Dosimetric Evaluation of High Energy Electron Beams Applied in Radiotherapy
AYMAN G. STOHY
 
linac QA.pptx
linac QA.pptxlinac QA.pptx
linac QA.pptx
Rupesh42492
 
Volumetric Modulated Arc Therapy
Volumetric Modulated Arc TherapyVolumetric Modulated Arc Therapy
Volumetric Modulated Arc Therapyfondas vakalis
 
Flattening filter Free
Flattening filter FreeFlattening filter Free
Beam Directed Radiotherapy - methods and principles
Beam Directed Radiotherapy - methods and principlesBeam Directed Radiotherapy - methods and principles
Beam Directed Radiotherapy - methods and principlesSantam Chakraborty
 
TISSUE PHANTOM RATIO - THE PHOTON BEAM QUALITY INDEX
TISSUE PHANTOM RATIO - THE PHOTON BEAM QUALITY INDEXTISSUE PHANTOM RATIO - THE PHOTON BEAM QUALITY INDEX
TISSUE PHANTOM RATIO - THE PHOTON BEAM QUALITY INDEX
Victor Ekpo
 
GAMMA KNIFE , X-KNIFE AND CYBERKNIFE
GAMMA KNIFE , X-KNIFE AND CYBERKNIFE GAMMA KNIFE , X-KNIFE AND CYBERKNIFE
GAMMA KNIFE , X-KNIFE AND CYBERKNIFE
Pooja Gupta
 
Helical Tomotherapy
Helical TomotherapyHelical Tomotherapy
Helical Tomotherapy
Santam Chakraborty
 
Srs and sbrt 2 dr.kiran
Srs and sbrt 2 dr.kiranSrs and sbrt 2 dr.kiran
Srs and sbrt 2 dr.kiran
Kiran Ramakrishna
 
planning systems in radiotherapy
 planning systems in radiotherapy planning systems in radiotherapy
planning systems in radiotherapyfondas vakalis
 
EPID AND CBCT ON RADIATION THERAPY
EPID AND CBCT ON RADIATION THERAPYEPID AND CBCT ON RADIATION THERAPY
EPID AND CBCT ON RADIATION THERAPY
anju k.v.
 
TRS 398 (Technical Report Series)
TRS 398 (Technical Report Series)TRS 398 (Technical Report Series)
TRS 398 (Technical Report Series)
Vinay Desai
 

What's hot (20)

EXTERNAL PHOTON BEAMS THERAPY (PART 2)
EXTERNAL PHOTON BEAMS THERAPY (PART 2)EXTERNAL PHOTON BEAMS THERAPY (PART 2)
EXTERNAL PHOTON BEAMS THERAPY (PART 2)
 
Principles of beam direction and use of simulators
Principles of beam direction and use of simulators Principles of beam direction and use of simulators
Principles of beam direction and use of simulators
 
Isodose lines
Isodose linesIsodose lines
Isodose lines
 
Dose volume histogram
Dose volume histogramDose volume histogram
Dose volume histogram
 
Measurement of absorbed dose
Measurement of absorbed doseMeasurement of absorbed dose
Measurement of absorbed dose
 
Mlc
MlcMlc
Mlc
 
Manchester system_Dr.Supriya
Manchester system_Dr.SupriyaManchester system_Dr.Supriya
Manchester system_Dr.Supriya
 
Dosimetric Evaluation of High Energy Electron Beams Applied in Radiotherapy
Dosimetric Evaluation of High Energy Electron Beams Applied in RadiotherapyDosimetric Evaluation of High Energy Electron Beams Applied in Radiotherapy
Dosimetric Evaluation of High Energy Electron Beams Applied in Radiotherapy
 
linac QA.pptx
linac QA.pptxlinac QA.pptx
linac QA.pptx
 
Volumetric Modulated Arc Therapy
Volumetric Modulated Arc TherapyVolumetric Modulated Arc Therapy
Volumetric Modulated Arc Therapy
 
Flattening filter Free
Flattening filter FreeFlattening filter Free
Flattening filter Free
 
Beam Directed Radiotherapy - methods and principles
Beam Directed Radiotherapy - methods and principlesBeam Directed Radiotherapy - methods and principles
Beam Directed Radiotherapy - methods and principles
 
TISSUE PHANTOM RATIO - THE PHOTON BEAM QUALITY INDEX
TISSUE PHANTOM RATIO - THE PHOTON BEAM QUALITY INDEXTISSUE PHANTOM RATIO - THE PHOTON BEAM QUALITY INDEX
TISSUE PHANTOM RATIO - THE PHOTON BEAM QUALITY INDEX
 
GAMMA KNIFE , X-KNIFE AND CYBERKNIFE
GAMMA KNIFE , X-KNIFE AND CYBERKNIFE GAMMA KNIFE , X-KNIFE AND CYBERKNIFE
GAMMA KNIFE , X-KNIFE AND CYBERKNIFE
 
Helical Tomotherapy
Helical TomotherapyHelical Tomotherapy
Helical Tomotherapy
 
Srs and sbrt 2 dr.kiran
Srs and sbrt 2 dr.kiranSrs and sbrt 2 dr.kiran
Srs and sbrt 2 dr.kiran
 
planning systems in radiotherapy
 planning systems in radiotherapy planning systems in radiotherapy
planning systems in radiotherapy
 
EPID AND CBCT ON RADIATION THERAPY
EPID AND CBCT ON RADIATION THERAPYEPID AND CBCT ON RADIATION THERAPY
EPID AND CBCT ON RADIATION THERAPY
 
TRS 398 (Technical Report Series)
TRS 398 (Technical Report Series)TRS 398 (Technical Report Series)
TRS 398 (Technical Report Series)
 
Dosimetry
DosimetryDosimetry
Dosimetry
 

Similar to Brachytherapy dosimetry

Brachytherapy msc lecture sam copy
Brachytherapy msc lecture sam copyBrachytherapy msc lecture sam copy
Brachytherapy msc lecture sam copy
Ayodele Dinyo
 
Brachytherapy_1_Orton.pdf
Brachytherapy_1_Orton.pdfBrachytherapy_1_Orton.pdf
Brachytherapy_1_Orton.pdf
ShounakKamat1
 
Brachytherapy.ar
Brachytherapy.arBrachytherapy.ar
Brachytherapy.ar
raazvarma
 
Co60 vs Ir192
Co60 vs Ir192Co60 vs Ir192
Co60 vs Ir192
Sambasivaselli R
 
Radioisotopes and dose rates used for brachytherapy
Radioisotopes and dose rates used for brachytherapyRadioisotopes and dose rates used for brachytherapy
Radioisotopes and dose rates used for brachytherapy
Subhash Thakur
 
brachy1.pptx
brachy1.pptxbrachy1.pptx
brachy1.pptx
BBAdhikari
 
Cavity-enhanced Absorption Spectroscopy for Trace Gas Detection with Frontier
Cavity-enhanced Absorption Spectroscopy for Trace Gas Detection with FrontierCavity-enhanced Absorption Spectroscopy for Trace Gas Detection with Frontier
Cavity-enhanced Absorption Spectroscopy for Trace Gas Detection with Frontier
PerkinElmer, Inc.
 
Radiopharmaceutical presentation
Radiopharmaceutical presentationRadiopharmaceutical presentation
Radiopharmaceutical presentation
laraib jameel
 
Out put calibration of co60
Out put calibration of co60Out put calibration of co60
Out put calibration of co60
KangkanDas3
 
L10 datta lecture on industrial radiation sources
L10 datta lecture on industrial radiation sourcesL10 datta lecture on industrial radiation sources
L10 datta lecture on industrial radiation sources
Mahbubul Hassan
 
Dosimetry and equioment.pptx
Dosimetry and equioment.pptxDosimetry and equioment.pptx
Dosimetry and equioment.pptx
Eba Abera
 
Physical society presentation ashik.pptx
Physical society presentation ashik.pptxPhysical society presentation ashik.pptx
Physical society presentation ashik.pptx
AshikurRahman204838
 
Internal radiation dosimetry
Internal radiation dosimetryInternal radiation dosimetry
Internal radiation dosimetry
Dr. Pradeep chaurasia
 
NMR Spectroscopy By Himaja Donthula
NMR Spectroscopy By Himaja DonthulaNMR Spectroscopy By Himaja Donthula
NMR Spectroscopy By Himaja Donthula
himaja donthula
 
Evolution of Intra-cavitary Brachytherapy
Evolution of Intra-cavitary BrachytherapyEvolution of Intra-cavitary Brachytherapy
Evolution of Intra-cavitary Brachytherapy
Dr Boaz Vincent
 
Radiation dosimtery princicles
Radiation dosimtery princiclesRadiation dosimtery princicles
Radiation dosimtery princicles
Sabari Kumar
 
Modern Medical Application methodologies: Brachytherapy, Neutron Capture Ther...
Modern Medical Application methodologies: Brachytherapy, Neutron Capture Ther...Modern Medical Application methodologies: Brachytherapy, Neutron Capture Ther...
Modern Medical Application methodologies: Brachytherapy, Neutron Capture Ther...
Haider Ali Malik
 
Instrumentation: Liquid and Gas Sensing - VE2013
Instrumentation: Liquid and Gas Sensing - VE2013Instrumentation: Liquid and Gas Sensing - VE2013
Instrumentation: Liquid and Gas Sensing - VE2013
Analog Devices, Inc.
 
Project introdection
Project introdection Project introdection
Project introdection
RafalAlGhrairi1
 
Brachytherapy And Gyn Malignancy
Brachytherapy And Gyn MalignancyBrachytherapy And Gyn Malignancy
Brachytherapy And Gyn Malignancyfondas vakalis
 

Similar to Brachytherapy dosimetry (20)

Brachytherapy msc lecture sam copy
Brachytherapy msc lecture sam copyBrachytherapy msc lecture sam copy
Brachytherapy msc lecture sam copy
 
Brachytherapy_1_Orton.pdf
Brachytherapy_1_Orton.pdfBrachytherapy_1_Orton.pdf
Brachytherapy_1_Orton.pdf
 
Brachytherapy.ar
Brachytherapy.arBrachytherapy.ar
Brachytherapy.ar
 
Co60 vs Ir192
Co60 vs Ir192Co60 vs Ir192
Co60 vs Ir192
 
Radioisotopes and dose rates used for brachytherapy
Radioisotopes and dose rates used for brachytherapyRadioisotopes and dose rates used for brachytherapy
Radioisotopes and dose rates used for brachytherapy
 
brachy1.pptx
brachy1.pptxbrachy1.pptx
brachy1.pptx
 
Cavity-enhanced Absorption Spectroscopy for Trace Gas Detection with Frontier
Cavity-enhanced Absorption Spectroscopy for Trace Gas Detection with FrontierCavity-enhanced Absorption Spectroscopy for Trace Gas Detection with Frontier
Cavity-enhanced Absorption Spectroscopy for Trace Gas Detection with Frontier
 
Radiopharmaceutical presentation
Radiopharmaceutical presentationRadiopharmaceutical presentation
Radiopharmaceutical presentation
 
Out put calibration of co60
Out put calibration of co60Out put calibration of co60
Out put calibration of co60
 
L10 datta lecture on industrial radiation sources
L10 datta lecture on industrial radiation sourcesL10 datta lecture on industrial radiation sources
L10 datta lecture on industrial radiation sources
 
Dosimetry and equioment.pptx
Dosimetry and equioment.pptxDosimetry and equioment.pptx
Dosimetry and equioment.pptx
 
Physical society presentation ashik.pptx
Physical society presentation ashik.pptxPhysical society presentation ashik.pptx
Physical society presentation ashik.pptx
 
Internal radiation dosimetry
Internal radiation dosimetryInternal radiation dosimetry
Internal radiation dosimetry
 
NMR Spectroscopy By Himaja Donthula
NMR Spectroscopy By Himaja DonthulaNMR Spectroscopy By Himaja Donthula
NMR Spectroscopy By Himaja Donthula
 
Evolution of Intra-cavitary Brachytherapy
Evolution of Intra-cavitary BrachytherapyEvolution of Intra-cavitary Brachytherapy
Evolution of Intra-cavitary Brachytherapy
 
Radiation dosimtery princicles
Radiation dosimtery princiclesRadiation dosimtery princicles
Radiation dosimtery princicles
 
Modern Medical Application methodologies: Brachytherapy, Neutron Capture Ther...
Modern Medical Application methodologies: Brachytherapy, Neutron Capture Ther...Modern Medical Application methodologies: Brachytherapy, Neutron Capture Ther...
Modern Medical Application methodologies: Brachytherapy, Neutron Capture Ther...
 
Instrumentation: Liquid and Gas Sensing - VE2013
Instrumentation: Liquid and Gas Sensing - VE2013Instrumentation: Liquid and Gas Sensing - VE2013
Instrumentation: Liquid and Gas Sensing - VE2013
 
Project introdection
Project introdection Project introdection
Project introdection
 
Brachytherapy And Gyn Malignancy
Brachytherapy And Gyn MalignancyBrachytherapy And Gyn Malignancy
Brachytherapy And Gyn Malignancy
 

More from Sabari Kumar

Biological effects of radiation
Biological effects of radiationBiological effects of radiation
Biological effects of radiation
Sabari Kumar
 
Therapeutic nuclear medicine
Therapeutic nuclear medicineTherapeutic nuclear medicine
Therapeutic nuclear medicine
Sabari Kumar
 
Source transport
Source transportSource transport
Source transport
Sabari Kumar
 
Icrp60
Icrp60Icrp60
Icrp60
Sabari Kumar
 
Magna field irradiation
Magna field irradiationMagna field irradiation
Magna field irradiation
Sabari Kumar
 
CT scanner
CT scannerCT scanner
CT scanner
Sabari Kumar
 
Charged particle interaction with matter
Charged particle interaction with matterCharged particle interaction with matter
Charged particle interaction with matter
Sabari Kumar
 
Interaction of radiation with matter
Interaction of radiation with matterInteraction of radiation with matter
Interaction of radiation with matter
Sabari Kumar
 

More from Sabari Kumar (8)

Biological effects of radiation
Biological effects of radiationBiological effects of radiation
Biological effects of radiation
 
Therapeutic nuclear medicine
Therapeutic nuclear medicineTherapeutic nuclear medicine
Therapeutic nuclear medicine
 
Source transport
Source transportSource transport
Source transport
 
Icrp60
Icrp60Icrp60
Icrp60
 
Magna field irradiation
Magna field irradiationMagna field irradiation
Magna field irradiation
 
CT scanner
CT scannerCT scanner
CT scanner
 
Charged particle interaction with matter
Charged particle interaction with matterCharged particle interaction with matter
Charged particle interaction with matter
 
Interaction of radiation with matter
Interaction of radiation with matterInteraction of radiation with matter
Interaction of radiation with matter
 

Recently uploaded

Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
SAMIR PANDA
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
ChetanK57
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
muralinath2
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
Areesha Ahmad
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
ossaicprecious19
 
EY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxEY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptx
AlguinaldoKong
 
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
ssuserbfdca9
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
Health Advances
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
muralinath2
 
role of pramana in research.pptx in science
role of pramana in research.pptx in sciencerole of pramana in research.pptx in science
role of pramana in research.pptx in science
sonaliswain16
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Sérgio Sacani
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
muralinath2
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
pablovgd
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
Areesha Ahmad
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
Sérgio Sacani
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
RenuJangid3
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
moosaasad1975
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
kumarmathi863
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
Sérgio Sacani
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Sérgio Sacani
 

Recently uploaded (20)

Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
 
EY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxEY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptx
 
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
 
role of pramana in research.pptx in science
role of pramana in research.pptx in sciencerole of pramana in research.pptx in science
role of pramana in research.pptx in science
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
 

Brachytherapy dosimetry

  • 1. Brachytherapy Dosimetry (TG 43 Formulation) SABARI KUMAR P M.Sc. Radiation Physics
  • 2. OUTLINE Introduction Sources used in Brachy Source Specification and its relation Source Calibration Methods Exposure Rate Method Well type chamber Method Solid Phantom Method  Dose Distribution around sources TG 43 Formulation
  • 3. Introduction Brachytherapy also named as Curie Therapy or Radium Therapy It is a special type of Radiotherapy treatment technique in which irradiation happen by placing radio nuclide inside or near the tumor A high dose can be delivered locally to the tumor with rapid dose falloff in the surrounding tissues It generates highly conformal dose distribution in the target volume Mainly two types of sources are used such as: Sealed sources: Two sources with same activity may emit different amount of energy due to encapsulation. Hence dose rate may differ.  Unsealed sources: Due to no encapsulation, two sources with same activity emit same amount of energy. Hence dose rate becomes same.
  • 4. Based on source placement, different classifications done in Brachytherapy such as  Intracavitary Brachytherapy : - source is placed in body cavities  Interstitial Brachytherapy - source is inserted into tumor  Surface Mould - source is placed externally near the tumor  Intra Luminal & Intra Vascular - sub classification of Intracavitary
  • 5. Based on dose rate used to treat tumor again Brachytherapy classified as Low dose rate (LDR) : <2Gy/h dose rate Medium Dose rate (MDR): >2Gy/h to <10Gy/h dose rate High Dose rate(HDR) : >10Gy/h dose rate Pulse Dose rate (PDR) : <1Gy/h HDR becomes used as PDR Based on source used in Brachytherapy, again two techniques introduced such as Permanent Implantation : Au-198, I-125, Pd-103 Temporary Implantation : Cs-137, Ir-192, Co-60 and Ra-226
  • 6. Desirable Properties of Brachytherapy Sources:  Source may be naturally available or artificially obtained  Optimum Gamma ray emission should be high enough to avoid increased energy deposition in bone and to minimize scatter. At the same time, it must be low to meet protection requirements  Long Half life is required for permanent storage and decay correction should minimum  Charged Particle emission should be absent  Should not be gaseous disintegration product  should have high specific activity  Possible to available in different shapes, sizes  should be insoluble, nontoxic and not in powder form
  • 7. Sources used in Brachytherapy 1. Radium -226: First source used in Brachytherapy. It is a naturally available source. It decays to Pb-206 by emitting 0.83MeV (Average) energy. Due to high exposure, hazardous bi-product (Radon – 222) and low specific activity ( 0.98 Ci/g) present usage stopped permanently. 2. Cesium 137: Cs- 137 is a nuclear fission by product and decays to Ba -137 by emitting 0.662MeV gamma energy. Its low specific activity (50Ci/g) limited this usage in LDR only. 3. Cobalt – 60: Co-60 is a neutron activated product, which decays to Ni-60 by emitting 1.25MeV (Average) energy. High specific activity (200 Ci/g) makes its wide usage in Brachy earlier. But due to short half life (5.26Y) and cost effective, no longer used at present in Brachy. 4. Gold – 198: Au-198 is produced by nuclear activation and it decays to Hg-138 by emitting 0.412MeV energy. Short half life ( 2.6days) makes this usage in permanent implantation technique.
  • 8. 5. Iodine – 125: It decays via Electron Capture to Te-125 and emits 0.35MeV gamma energy. Relatively longer half life (59.4 days), gained more advantage in permanent implant technique over Au-198, Rn-222. But dosimetry is much more complex due to complex energy spectrum. 6. Palladium – 103: It is the substitute for I-125. It decays to Rh-103 via electron capture and emits 0.021MeV energy. Having short half life (17 days) compared to I-125, it may provide biologic advantage in permanent implants. 7. Iridium -192: It is more popular as a replacement of Ra-226. It decays to Pt-192 by emitting 0.361MeV (Average) energy. High Specific activity ( 400 Ci/g) and short half life (73.8 days) makes this source more popular in temporary implantation in HDR. 8. with all above, few of other Radioactive isotopes such as Ytterbium – 169, Thulium – 170, Phosphor – 32, Yttrium - 90 and Californium – 252 also used in Brachytherapy.
  • 9. Source Specification Each Brachy source has a specified source strength that is used to calculate dose rate. Source strength can be stated in terms of one of several interrelated physical quantities such as – Radium Equivalent Mass, Apparent Activity, Air Kerma Rate (RAKR), Air kerma Strength, Exposure Rate . Radium Equivalent Mass: Ra-226 was predominant source in Brachy in early days. So source strength was defined by Mass of Ra For non Radium sources, strength can be specified by Ra Eq. Mass Relation between mg Ra Eq and its activity is 1 mg Ra Eq = 1 mCi of Ra
  • 10. Exposure Rate Constant: The exposure rate constant defines as the Exposure at a unit distance from the point source of activity A gamma Here Ʈδ = Exposure Rate constant (R–m2/Ci – hr (or) R-cm2/mCi - hr) r = Distance from source and Measurement point (P) (m2) X(P) = Exposure at point P (R) A = Activity of source (Ci) Conditions : 1. Source should be a bare point source 2. The photon fluence is neither attenuated nor scattered in the distance ‘r’ 3. When δ = 0, the exposure rate constant includes all the photons emitted by the radionuclide A )P(X.r2 
  • 11. Air Kerma Rate Constant: From the relation between exposure (X), air kerma (Ka) and Exposure rate constant, Here Ka is expressed in μGy/hr Units: μGy – m2/Ci – hr Reference Air Kerma Rate (RAKR): If Air kerma rate is defined at 1 meter distance and corrected for air attenuation and scattering, then it becomes Reference Air Kerma Rate (RAKR). It is indicated by KR(dref) Units: Gy/Sec a 2 k, K A r 
  • 12. Apparent Activity: Basically, the source is not bare point source. It is encapsulated by filter material which introduces an attenuation. Thus reduction in air kerma rate happens. To compensate this attenuation effect, Apparent Activity is introduced. If the source is calibrated under Air kerma rate conditions, the source strength may be specified as Apparent Activity or Effective Activity. Here Aeff = A x Katt Katt – source encapsulation attenuation Thus, Apparent activity can be determined by dividing measured air kerma with Air kerma rate constant (or) exposure rate with exposure rate constant. Ka a 2 eff )P(K.r A  
  • 13. Air Kerma Strength: This was introduced by AAPM in 1987 to replace exposure rate. The product of air kerma rate in free space and the square of the distance of calibration point from the source centre is called as Air kerma Strength. Sak = Ka x r2 (or) Ʈak x Kattn x A Units: μGy m2/hr  For linear sources, Ka is measured at a point along the mid perpendicular line of the source at a distance very much larger than active length of the source. 1 μGy – m2/hr = 0.138 mg Ra Eq  AAPM 43 recommends a shorthand notation for air kerma strength as “U” 1 U = 1 μGy – m2/hr
  • 14. Standardization of Brachytherapy Sources As like external beam therapy measurements, Brachytherapy measurements should also be traceable to the Primary standardization lab. In Brachy, sources are standardized in terms of RAKR or Air kerma Strength. Based on the source strength, three methods are developed. 1. Measurement using air setup with ion chamber 2. Measurement using well type ion chamber 3. Measurement using Solid Phantom of well defied geometry In Air measurement setup
  • 15. Measurement using Air setup: The arrangement consists of a large source to ion chamber distance relative to source and detector dimensions.  For this a calibrated large volume chamber can be used for low activity sources. Calibration method for large volume chamber in Lab : Ka at 1 meter (at point P) for working standard : X Gy/h current at P for the large volume chamber : Y pA Air kerma calibration factor NK = (X/Y) Gy/pA . hr For a source to be calibrated , consider the current reading Y’ at point P, then Ka of the source at P = NK . Y’ Gy/h After applying Air attenuation factor (Kattn) and Scatter Radiation correction factor (Kscatt) and non uniformity correction factor (Kn) the KR becomes KR = NK. Kattn . Kscatt . Kn . Y’
  • 16. Corrected Reading Y’ = M . Ku. Kt. KP. KTP. Kion. Kv. Kwall. Kappl M – Meter Reading (pA) Ku – Unit conversion factor from air to water/medium Kt – Transit time correction factor KP – Polarity correction factor KTP – Temperature and Pressure correction factor Kion – Ion recombination factor Kv – chamber volume correction factor Kwall – chamber wall attenuation & scattering correction factor Kappl – Applicator attenuation correction factor Generally NK – air kerma calibration factor for Co-60 and Cs-137 can provided by PSDL or SSDL. For other than these sources, Interpolation between two neighboring calibration point is used.  For low energy radio nuclides ( I-125 and Pd-103) large volume chambers are required at the same time, for routine clinical procedures, this method is not practical.
  • 17. Well chamber Measurement: Most widely used method for calibration sources of any radio nuclide by using Well type ion chamber (or) 4πr-chamber (or) isotope calibrator (or) Re-entrant type ion chamber. Calibration of well chamber is made either 1. with source previously calibrated using air setup 2. with source of the same radio nuclide calibrated by a PSDL These chambers are calibrated in terms of RAKR or Air kerma Strength. Source Strength of a Brachy source by using well chamber is determined from, KR = NKR . M . KP . KTP . Kion. Kappl Here, NKR – RAKR calibration factor of chamber
  • 18. Cont.. Due to thicker walls of well type chamber, the energy and source type dependence of the response of well type chambers are much more pronounced. Energy dependence of the chamber arises from absorption and scattering of photons and secondary electrons in the chamber walls and the gas. The oblique filtration through the source encapsulation affects the chamber response by photon absorption and thus produces change in the energy spectrum. Source dimensions and source position in well chamber also affects the chamber response.
  • 19. Measurement using Solid Phantom: Phantom Measurement is superior than air measurement and equivalent to well type chamber measurement.  The RAKR or Air Kerma Strength depends on phantom specific geometry, material and radio nuclide to be used.  The generalized formula for all sources and all solid phantom designs published by DGMP as KR = NK . M . KαP . Kph Here NK – Chamber Calibration Factor M – corrected Meter Reading KαP - Perturbation correction factor (Medium changing from air to Phantom) Kph - Phantom correction factor density correction factor from water to water equivalent meterial  To minimize the source position dependence, a plastic SF catheter is used.
  • 20. Dose Distribution of Brachy sources In early days the treatment were purely empirical based on trail and error i.e certain amount of Ra (mg) is placed for certain (hours) to treat various types of tumors. This was popular as “mgh” method. But at present, new techniques came for dose distribution calculations around the source. The kerma rate at a point in air or in tissue from seed can be calculated using Air kerma Rate Constant The dose at a point from line source can be determined using Sievert Integral Method. For ideal Point source: 1. The air kerma rate can be calculated based on the RAKR and inverse square law, at point of interest in air becomes Ka(r) = Kr (r0/r)2 2. The absorbed dose rate to air in air becomes Da(r) = Kcol,a(r) = Ka(r) . (1.- g) = Kr . (1- g) . (r0/r)2
  • 21. 3. The absorbed dose rate to water in air medium becomes Dw(r) = Da(r) . (μen/ρ)a,w = Kr . (1- g) . (r0/r)2 . (μen/ρ)a,w 4. The absorbed dose rate to water in water medium becomes Dw(r) = Kr . (1- g). (r0/r)2 . (μen/ρ)a,w . fas,w(r) In terms of Air kerma strength, Dw(r) = Sk. (1- g). (1/r)2 . (μen/ρ)a,w . fas,w(r) From the above equation, one can conclude that the absorbed dose is depends on emitted photon energy spectrum (radio nuclide ) , distance, absorption and scattering on medium , g value and mass energy absorption coefficient. But Practically g values are zero for Brachytherapy sources. The mass energy absorption coefficient for high energy radio nuclides is insensitive to source designs. Thus the photon spectra changes due to source design only. So the above equation can re-written as Dw(r) = Kr . (r0/r)2 . (μen/ρ)a,w . fas,w(r)
  • 22. For Line source: (In air) In real situation, the source is not a point source. Sources have finite dimensions. At This condition, the total source length is dividing into small elementary sources and applying Inverse Square Law and filtration corrections to each Consider a source of active Length ‘L’ and filtration ‘t’. The kerma rate Ka at point ‘P’ contributed by the source element dx length is given by, Here A – Activity Ʈka – Air Kerma rate constant μ’ – Effective attenuation co-efficient for filter By integrating the above equation and taking account of θ1 and θ2        de L dx Y A )P(K 2 1 / tSec.ka a   tSec. 2 ka a / e L dx r A )P(dK
  • 23. This equation is called Sievert Integral equation and can be evaluated by numerical method. To compute accurately air kerma rate using this method such as 1. Self Absorption correction in the source material is needed 2. Wall thickness should be corrected to internal radius of source i.e. Effective attenuation co efficient needed with filter thickness Inverse square Law effect:  In the linear sources, at points close to source, the exposure rate is less. (due oblique filtration)  As distance increases, the response of line source follows as like as point source response.
  • 24. In Medium:  For calculation of the dose in water or medium, the perturbation correction (WPC) for this distance, WPC(Y Secθ) should be incorporated in the integral expression. Here WPC – (Kattn)w.(Kscat)w Limitations: The Sievert Integral method will not account for filtration in the paraxial regions (A & A’) (introduces significant errors and practically break downs in the extreme oblique directions) A A’ )YSec(WPC.de L dx Y A )P(K 2 1 / tSec.ka a       
  • 25. Modular Dose Calculation Model : TG 43 In 1995, AAPM – TG 43 taken calculation model proposed by ICWG and published recommendations on dosimetry formalism and dosimetry parameters for Interstitial Brachytherapy sources. Primarily, these were considered only for LDR sources. But later, virtually implemented to HDR and PDR also. Previous dose calculations were based on apparent activity, Eq. Mass of Ra, Exposure Rate constants and tissue attenuation coefficients. These did not account for source to source differences in active core constructions and encapsulation design. The TG 43 introduced and incorporated dose rate constants and specific source design dosimetric parameters. TG 43 is simple to implement and small number of parameters are used which can easily extract form Monte Carlo calculated dose rate distribution around the sources in a water equivalent medium.
  • 26. For the reference point of TG 43 formalism becomes, Dw(r0,θ0) = Kr . G(r0,θ0) . (μen/ρ)a,w . fas,w(r0,θ0) -----------(1) For the point of interest, TG 43 formalism becomes, Dw(r,θ) = Kr . G(r,θ) . (μen/ρ)a,w . fas,w(r,θ) -----------(2) From the above equations, Dw(r,θ) = Dw(r0,θ0). G(r,θ)/ G(r0,θ0) . fas,w(r,θ)/ fas,w(r0,θ0) = Sk . Dw(r0,θ0)/Sk . G(r,θ)/ G(r0,θ0) . fas,w(r,θ)/ fas,w(r0,θ0) Finally , the equation can re written as, Dw(r,θ) = Sk . Λ . G(r,θ)/ G(r0,θ0) . g(r) . F(r,θ) Where, Λ = Dw(r0,θ0)/Sk (dose rate constant) g(r) . F(r,θ) = fas,w(r,θ)/ fas,w(r0,θ0) P R θ θ
  • 27. Reference Medium :Water (Homogeneous medium) Reference Data : Monte Carlo Simulation data Source Geometry : All Clinically approved source dimensions Reference Dose calculation point : A point lying on the transverse bisector of the source at a distance of 1cm from its center that’s why r0 Point of Measurement : Dose rate at point which is on radial line at an angle w.r.to source Formalism: Dose = S x dose rate constant x inverse square law factor x absorption/scatter correction factor in the medium x absorption/scattering correction factor in the source Here Sak – Air kerma strength in U G(r,θ) – geometric function at radial distance r and polar angle θ for point source ==> G(r,θ) = 1/r2 for line source ==>G(r,θ) = (θ -θ )/LY ),r(F)r(g ),r(G ),r(G S),r(D 00 ak    
  • 28. G(r0,θ0) – geometric function at reference point (r0 = 1 cm and θ0 =900) g(r) – Radial dose function which depends on photon absorption and scatter in the medium along the transverse axis F(r,θ) – anisotropy function that considers the effects of absorption and scatter of the photons within the source active core and encapsulation material. It is defined as The angular dependence of the dose rate value for a given radial distance r, corrected for the distance related effect using the effective inverse square law correction. )90,cm1r(G)90,cm1r(D )90,cm1r(G)90,r(D )r(g 0 00 0 00 0 00 0    ),r(G)90,cm1r(D )90,cm1r(G),r(D ),r(F 0 00 0 00   
  • 29. Λ (Lamda) – Dose rate constant It is defined as the dose rate to water in water at the reference point (1cm, 00) per unit air kerma strength Sk. This will depends on both the radionuclide and source design. If source is a point source then, Φan – distance dependent average anisotropy function φan = 4π average dose rate /dose rate along the transverse axis ak 0 00 S )90,cm1r(D   an2ak )r(g r 1 S)r(D 